GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt/GSK3b/b-catenin pathway

Journal of Molecular Endocrinology

Volumn 55, Issue 3, 2015, Pages 245-262

  Ying, Ying ^a   Zhu, Huazhang ^a   Liang, Zhen ^a,b   Ma, Xiaosong ^a   Li, Shiwei ^a  

^a Shenzhen University School of Medicine   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

Author keywords

Akt; Apoptosis; B catenin; Cardiomyocytes; GLP1; GLP1R; GSK3B; Palmitate

Indexed keywords

8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; BETA CATENIN; CASPASE 3; CD36 ANTIGEN; FATTY ACID TRANSPORTER; GLUCAGON LIKE PEPTIDE 1; GLYCOGEN SYNTHASE KINASE 3BETA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PALMITIC ACID; PROTEIN BCL 2; PROTEIN KINASE B; SHORT HAIRPIN RNA; SURVIVIN; TRIACYLGLYCEROL; CARDIOTONIC AGENT; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLYCOGEN SYNTHASE KINASE; PALMITIC ACID DERIVATIVE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ATTENUATION; CELL FRACTIONATION; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE SILENCING; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOFLUORESCENCE; LIPID STORAGE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; RNA STRUCTURE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CARDIAC MUSCLE CELL; CELL SURVIVAL; DRUG EFFECTS; GENETICS; LIPID METABOLISM; METABOLISM;

ANIMALS; ANTIGENS, CD36; APOPTOSIS; BETA CATENIN; CARDIOTONIC AGENTS; CELL SURVIVAL; GENE KNOCKDOWN TECHNIQUES; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; GLYCOGEN SYNTHASE KINASES; LIPID METABOLISM; MYOCYTES, CARDIAC; PALMITATES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84947713698     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-15-0155     Document Type: Article

References (54)

1. Ahren B 2004 GLP-1 and extra-islet effects. Hormone and Metabolic Research 36 842-845. (doi:10.1055/s-2004-826173)
2. Almeida M, Han L, Bellido T, Manolagas SC & Kousteni S 2005 Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by b-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. Journal of Biological Chemistry 280 41342-41351. (doi:10.1074/jbc.M502168200)
3. Baggio LL & Drucker DJ 2007 Biology of incretins: GLP-1 and GIP. Gastroenterology 132 2131-2157. (doi:10.1053/j.gastro.2007.03.054)
4. Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ & Husain M 2008 Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. Circulation 117 2340-2350. doi:10.1161/CIRCULATIONAHA.107.739938
5. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R & Birchmeier W 1996 Functional interaction of b-catenin with the transcription factor LEF-1. Nature 382 638-642. (doi:10.1038/382638a0)
6. Bergmann MW, Rechner C, Freund C, Baurand A, El Jamali A & Dietz R 2004 Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3 b and transcription factor b-catenin. Journal of Molecular and Cellular Cardiology 37 681-690. (doi:10.1016/j.yjmcc.2004.05.025)
7. Bose AK, Mocanu MM, Carr RD, Brand CL & Yellon DM 2005 Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes 54 146-151. (doi:10.2337/diabetes.54.1.146)
8. Boudina S & Abel ED 2007 Diabetic cardiomyopathy revisited. Circulation 115 3213-3223. (doi:10.1161/CIRCULATIONAHA.106.679597)
9. Bullock BP, Heller RS & Habener JF 1996 Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137 2968-2978. (doi:10.1210/endo.137.7.8770921)
10. Chabowski A, Coort SL, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ & Bonen A 2004 Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm. American Journal of Physiology. Endocrinology and Metabolism 287 E781-E789. (doi:10.1152/ajpendo.00573.2003)
11. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE & Schaffer JE 2001 A novel mouse model of lipotoxic cardiomyopathy. Journal of Clinical Investigation 107 813-822. (doi:10.1172/JCI10947)
12. Cousin SP, Hugl SR, Wrede CE, Kajio H, Myers MG Jr & Rhodes CJ 2001 Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic b-cell line INS-1. Endocrinology 142 229-240. (doi:10.1210/endo.142.1.7863)
13. Ding VW, Chen RH & McCormick F 2000 Differential regulation of glycogen synthase kinase 3b by insulin and WNT signaling. Journal of Biological Chemistry 275 32475-32481. (doi:10.1074/jbc.M005342200)
14. Fang ZY, Prins JB & Marwick TH 2004 Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocrinology Reviews 25 543-567. (doi:10.1210/er.2003-0012)
15. Fesik SW & Shi Y 2001 Controlling the caspases. Science 294 1477-1478. (doi:10.1126/science.1062236)
16. Fraze E, Donner CC, Swislocki AL, Chiou YA, Chen YD & Reaven GM 1985 Ambient plasma free fatty acid concentrations in noninsulin-depen-dent diabetes mellitus: evidence for insulin resistance. Journal ofClinical Endocrinology and Metabolism 61 807-811. (doi:10.1210/jcem-61-5-807)
17. Fukumoto S, Hsieh CM, Maemura K, Layne MD, Yet SF, Lee KH, Matsui T, Rosenzweig A, Taylor WG, Rubin JS et al. 2001 Akt participation in the Wnt signaling pathway through Dishevelled. Journal ofBiological Chemistry 276 17479-17483. (doi:10.1074/jbc.C000880200)
18. Glauser DA & Schlegel W 2007 The emerging role of FOXO transcription factors in pancreatic b cells. Journal ofEndocrinology 193 195-207. (doi:10.1677/JOE-06-0191)
19. Hahn JY, Cho HJ, Bae JW, Yuk HS, Kim KI, Park KW, Koo BK, Chae IH, Shin CS, Oh BH et al. 2006 Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. Journal of Biological Chemistry 28130979-30989. (doi:10.1074/jbc.M603916200)
20. Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B, Woodgett J, Kilter H & Force T 2003 Stabilization of b-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. PNAS 100 4610-4615. (doi:10.1073/pnas.0835895100)
21. Huelsken J & Birchmeier W 2001 New aspects of Wnt signaling pathways in higher vertebrates. Current Opinion in Genetics & Development 11 547-553. (doi:10.1016/S0959-437X(00)00231-8)
22. Kaga S, Zhan L, Altaf E & Maulik N 2006 Glycogen synthase kinase-3b/ b-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. Journal ofMolecular and Cellular Cardiology 40 138-147. (doi:10.1016/j.yjmcc.2005.09.009)
23. Koonen DP, Glatz JF, Bonen A & Luiken JJ 2005 Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochimica etBiophysica Acta 1736 163-180. (doi:10.1016/j.bbalip.2005.08.018)
24. Liu Z & Habener JF 2008 Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic b cell proliferation. Journal ofBiological Chemistry 283 8723-8735. (doi:10.1074/jbc. M706105200)
25. Luiken JJ, Koonen DP, Willems J, Zorzano A, Becker C, Fischer Y, Tandon NN, Van Der Vusse GJ, Bonen A & Glatz JF 2002 Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 51 3113-3119. (doi:10.2337/diabetes.51.10.3113)
26. Merrill AH Jr & Jones DD 1990 An update of the enzymology and regulation ofsphingomyelin metabolism. Biochimica et Biophysica Acta 10441-12. (doi:10.1016/0005-2760(90)90211-F)
27. Miller JR, Hocking AM, Brown JD & Moon RT 1999 Mechanism and function of signal transduction by the Wnt/b-catenin and Wnt/Ca2C pathways. Oncogene 18 7860-7872. (doi:10.1038/sj.onc.1203245)
28. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, Dal Bello B, Semigran MJ, Bielsa-Masdeu A, Dec GW et al. 1999 Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. PNAS 96 8144-8149. (doi:10.1073/pnas.96.14.8144)
29. Narula J, Arbustini E, Chandrashekhar Y & Schwaiger M 2001 Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes. Cardiology Clinics 19 113-126. (doi:10.1016/S0733-8651(05)70198-3)
30. Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ Riazi AM, Baggio LL, Henkelman RM, Husain M & Drucker DJ 2009 GLP1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes 58 975-983. (doi:10.2337/db08-1193)
31. Noyan-Ashraf MH, Shikatani EA, Schuiki I, Mukovozov I, Wu J, Li RK, Volchuk A, Robinson LA, Billia F, Drucker DJ et al. 2013 A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity. Circulation 127 74-85. (doi:10.1161/CIRCULATIONAHA.112.091215)
32. Peng T, Lu X, Lei M & Feng Q 2003 Endothelial nitric-oxide synthase enhances lipopolysaccharide-stimulated tumor necrosis factor-a expression via cAMP-mediated p38 MAPK pathway in cardiomyocytes. Journal ofBiological Chemistry 278 8099-8105. (doi:10.1074/jbc. M207288200)
33. Poornima I, Brown SB, Bhashyam S, Parikh P, Bolukoglu H & Shannon RP 2008 Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat. Circulation. Heart Failure 1 153-160. (doi:10.1161/CIRCHEARTFAILURE.108.766402)
34. Puthanveetil P, Wang Y, Zhang D, Wang F, Kim MS, Innis S, Pulinilkunnil T, Abrahani A & Rodrigues B 2011 Cardiac triglyceride accumulation following acute lipid excess occurs through activation of a FoxO1-iNOS-CD36 pathway. Free Radical Biology & Medicine 51 352-363. (doi:10.1016/j.freeradbiomed.2011.04.009)
35. Ravassa S, Zudaire A, Carr RD & Diez J 2011 Antiapoptotic effects of GLP1 in murine HL-1 cardiomyocytes. American Journal ofPhysiology. Heart and Circulatory Physiology 300 1361-1372. (doi:10.1152/ajpheart.00885.2010)
36. Rodrigues B, Cam MC & McNeill JH 1995 Myocardial substrate metabolism: implications for diabetic cardiomyopathy. Journal of Molecular and Cellular Cardiology 27 169-179. (doi:10.1016/S0022-2828(08)80016-8)
37. Salvesen GS & Duckett CS 2002 IAP proteins: blocking the road to death's door. Nature Reviews. Molecular Cell Biology 3 401-410. (doi:10.1038/nrm830)
38. Santini D, Abbate A, Scarpa S, Vasaturo F, Biondi Zoccai GG, Bussani R, De Giorgio F, Bassan F, Camilot D, Di Marino MP et al. 2004 Surviving acute myocardial infarction: survivin expression in viable cardiomyocytes after infarction. Journal ofClinical Pathology 57 1321-1324. (doi:10.1136/jcp.2004.018986)
39. Schumann H, Holtz J, Zerkowski HR & Hatzfeld M 2000 Expression of secreted frizzled related proteins 3 and 4 in human ventricular myocardium correlates with apoptosis related gene expression. Cardiovascular Research 45 720-728. (doi:10.1016/S0008-6363(99) 00376-4)
40. Sparagna GC, Hickson-Bick DL, Buja LM & McMillin JB 2000 A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. American Journal ofPhysiology. Heart and Circulatory Physiology 279 2124-2132.
41. Summers SA, Garza LA, ZhouH & Birnbaum MJ1998 Regulation ofinsulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Molecular and Cellular Biology 18 5457-5464. (doi:10.1128/MCB.18.9.5457)
42. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T & Reed JC 1998 IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Research 58 5315-5320.
43. Taurin S, Sandbo N, Qin Y, Browning D & Dulin NO 2006 Phosphorylation of b-catenin by cyclic AMP-dependent protein kinase. Journal of Biological Chemistry 281 9971-9976. (doi:10.1074/jbc.M508778200)
44. Thirunavukkarasu M, Han Z, Zhan L, Penumathsa SV, Menon VP & Maulik N 2008 Adeno-sh-b-catenin abolishes ischemic precondition-ing-mediated cardioprotection by downregulation of its target genes VEGF, Bcl-2, and survivin in ischemic rat myocardium. Antioxidants & Redox Signaling 10 1475-1484. (doi:10.1089/ars.2008.2042)
45. Timmers L, Henriques JP, de Kleijn DP, Devries JH, Kemperman H, Steendijk P, Verlaan CW, Kerver M, Piek JJ, Doevendans PA et al. 2009 Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. Journal ofthe American College of Cardiology 53 501-510. (doi:10.1016/j.jacc.2008.10.033)
46. Venkatesan B, Prabhu SD, Venkatachalam K, Mummidi S, Valente AJ, Clark RA, Delafontaine P & Chandrasekar B 2010 WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death. Cellular Signalling 22 809-820. (doi:10.1016/j.cellsig.2010.01.005)
47. Verdecia MA, Huang H, Dutil E, Kaiser DA, Hunter T & Noel JP 2000 Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nature Structural Biology 7 602-608. (doi:10.1038/77929)
48. Wang D, Luo P, Wang Y, Li W, Wang C, Sun D, Zhang R, Su T, Ma X, Zeng C et al. 2013 Glucagon-like peptide-1 protects against cardiac micro-vascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism. Diabetes 62 1697-1708. (doi:10.2337/db12-1025)
49. Wu QL, Shen T, Shao LL, Ma H & Wang JK 2012 Ischemic postconditioning mediates cardioprotection via PI3K/ GSK-3b/b-catenin signaling pathway in ischemic rat myocardium. Shock 38 165-169. (doi:10.1097/SHK.0b013e31825b5633)
50. Xi XH, Wang Y, Li J, Wang FW, Tian GH, Yin MS, Mu YL & Chong ZZ 2015 Activation of Wnt/b-catenin/GSK3b signaling during the development of diabetic cardiomyopathy. Cardiovascular Pathology 24 179-186.(doi:10.1016/j.carpath.2014.12.002)
51. Ying Y, Li L, Cao W, Yan D, Zeng Q Kong X, Lu L, Yan M, Xu X, Qu J et al. 2012 The microtubule associated protein syntabulin is required for glucose-stimulated and cAMP-potentiated insulin secretion. FEBS Letters 586 3674-3680. (doi:10.1016/j.febslet.2012.08.025)
52. Zamzami N, Brenner C, Marzo I, Susin SA & Kroemer G 1998 Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 16 2265-2282. (doi:10.1038/sj.onc.1201989)
53. Zhou H, Summers SA, Birnbaum MJ & Pittman RN 1998 Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. Journal ofBiological Chemistry 273 16568-16575. (doi:10.1074/jbc.273.26.16568)
54. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L & Unger RH 2000 Lipotoxic heart disease in obese rats: implications for human obesity. PNAS 97 1784-1789. (doi:10.1073/pnas.97.4.1784)